Legal Opinion
Dahl v. HEM Pharmaceuticals Corp.
District Court, S.D. New York
Decided October 26, 1994No. 94 CIV 563 AGSPublishedCited by 6 opinions
1Opinion of the Court
ORDER
SCHWARTZ, District Judge:
This is a diversity action that was removed by defendant from New York State Supreme Court. The Complaint alleges two causes of action arising out of plaintiffs participation in a medical clinical trial of an experimental pharmaceutical compound manufactured by defendant called Ampligen, which is used for the treatment of Chronic Fatigue Immune Dysfunction Syndrome (“CFIDS”). The first cause of action is for lack of informed consent; plaintiff alleges that defendant was aware of but, in violation of its duties and obligations, failed to disclose to plaintiff “the…
2Cases cited13 opinions
- Factors Etc., Inc. And Boxcar Enterprises Inc. v. Pro Arts, Inc. And Stop and Shop Companies, Inc.Court of Appeals for the Second Circuit · 1978
- Filmline (Cross-Country) Productions, Inc. And Yellowbill Finance Limited v. United Artists CorporationCourt of Appeals for the Second Circuit · 1989
- A. J. Industries, Inc., a Delaware Corporation v. United States District Court for the Central District of CaliforniaCourt of Appeals for the Ninth Circuit · 1974
- Viacom International, Inc. v. Melvin Simon Productions, Inc.District Court, S.D. New York · 1991
- Foster v. Litton Industries, Inc.District Court, S.D. New York · 1977
8 more not listed; retrieve them via the Exa API.
3Cited by6 opinions
- Jetblue Airways Corp. v. Helferich Patent Licensing, LLCDistrict Court, E.D. New York · 2013
- In Re Consolidated Parlodel LitigationDistrict Court, D. New Jersey · 1998
- APA Excelsior III L.P. v. Premiere Technologies, Inc.District Court, S.D. New York · 1999
- Walker v. Jon Renau Collection, Inc.District Court, S.D. New York · 2005
- Official Committee of Asbestos of G-I Holding, Inc. v. HeymanDistrict Court, S.D. New York · 2004
1 more not listed; retrieve them via the Exa API.